Sbi Securities Co., Ltd. Pds Biotechnology Corp Transaction History
Sbi Securities Co., Ltd.
- $3.48 Trillion
- Q2 2025
A detailed history of Sbi Securities Co., Ltd. transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 207 shares of PDSB stock, worth $254. This represents 0.0% of its overall portfolio holdings.
Number of Shares
207
Previous 106
95.28%
Holding current value
$254
Previous $126,000
118.25%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PDSB
# of Institutions
57Shares Held
7.33MCall Options Held
98.2KPut Options Held
0-
Armistice Capital, LLC New York, NY2.24MShares$2.75 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$2.4 Million0.0% of portfolio
-
Ubs Group Ag543KShares$667,9150.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$598,9690.0% of portfolio
-
Geode Capital Management, LLC Boston, MA418KShares$514,0580.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $35M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...